Abbotsford, Australia
Abbotsford, Australia

Time filter

Source Type

Wiseguyreports.Com Adds “Sleep Apnea Diagnostic and Therapeutic Devices -Market Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database This report studies sales (consumption) of Sleep Apnea Diagnostic and Therapeutic Devices in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Sleep Apnea Diagnostic and Therapeutic Devices in these regions, from 2012 to 2022 (forecast), like Split by product Types, with Sales, Revenue, Price and Gross Margin, market share and growth rate of each type, can be divided into Sleep Apnea Diagnostic Device Sleep Apnea Therapeutic Devices Mandibular Advancement Devices Tongue Retaining Devices Others Split by applications, this report focuses on sales, market share and growth rate of Sleep Apnea Diagnostic and Therapeutic Devices in each application, can be divided into Household Hospital and Clinics Recovery Center Others Global Sleep Apnea Diagnostic and Therapeutic Devices Sales Market Report 2017 1 Sleep Apnea Diagnostic and Therapeutic Devices Overview 1.1 Product Overview and Scope of Sleep Apnea Diagnostic and Therapeutic Devices 1.2 Classification of Sleep Apnea Diagnostic and Therapeutic Devices 1.2.1 Sleep Apnea Diagnostic Device 1.2.2 Sleep Apnea Therapeutic Devices 1.2.2.1 Mandibular Advancement Devices 1.2.2.2 Tongue Retaining Devices 1.2.3 Others 1.3 Applications of Sleep Apnea Diagnostic and Therapeutic Devices 1.3.1 Household 1.3.2 Hospital and Clinics 1.3.3 Recovery Center 1.3.4 Others 1.4 Sleep Apnea Diagnostic and Therapeutic Devices Market by Regions 1.4.1 USA Status and Prospect (2012-2022) 1.4.2 China Status and Prospect (2012-2022) 1.4.3 Europe Status and Prospect (2012-2022) 1.4.4 Japan Status and Prospect (2012-2022) 1.4.5 India Status and Prospect (2012-2022) 1.4.6 Southeast Asia Status and Prospect (2012-2022) 1.5 Global Market Size (Value and Volume) of Sleep Apnea Diagnostic and Therapeutic Devices (2012-2022) 1.5.1 Global Sleep Apnea Diagnostic and Therapeutic Devices Sales and Growth Rate (2012-2022) 1.5.2 Global Sleep Apnea Diagnostic and Therapeutic Devices Revenue and Growth Rate (2012-2022) 9 Global Sleep Apnea Diagnostic and Therapeutic Devices Manufacturers Analysis 9.1 Philips 9.1.1 Company Basic Information, Manufacturing Base and Competitors 9.1.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.1.2.1 Type one 9.1.2.2 Type two 9.1.3 Philips Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.1.4 Main Business/Business Overview 9.2 WEINMANN Geraete 9.2.1 Company Basic Information, Manufacturing Base and Competitors 9.2.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.2.2.1 Type one 9.2.2.2 Type two 9.2.3 WEINMANN Geraete Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.2.4 Main Business/Business Overview 9.3 MALLINCKRODT 9.3.1 Company Basic Information, Manufacturing Base and Competitors 9.3.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.3.2.1 Type one 9.3.2.2 Type two 9.3.3 MALLINCKRODT Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.3.4 Main Business/Business Overview 9.4 ResMed Limited 9.4.1 Company Basic Information, Manufacturing Base and Competitors 9.4.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.4.2.1 Type one 9.4.2.2 Type two 9.4.3 ResMed Limited Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.4.4 Main Business/Business Overview 9.5 Compumedics Limited 9.5.1 Company Basic Information, Manufacturing Base and Competitors 9.5.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.5.2.1 Type one 9.5.2.2 Type two 9.5.3 Compumedics Limited Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.5.4 Main Business/Business Overview 9.6 Watermark Medical 9.6.1 Company Basic Information, Manufacturing Base and Competitors 9.6.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.6.2.1 Type one 9.6.2.2 Type two 9.6.3 Watermark Medical Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.6.4 Main Business/Business Overview 9.7 Embla Systems 9.7.1 Company Basic Information, Manufacturing Base and Competitors 9.7.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.7.2.1 Type one 9.7.2.2 Type two 9.7.3 Embla Systems Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.7.4 Main Business/Business Overview 9.8 MRA Medical Ltd (Spiro Medical) 9.8.1 Company Basic Information, Manufacturing Base and Competitors 9.8.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.8.2.1 Type one 9.8.2.2 Type two 9.8.3 Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin MRA Medical Ltd (Spiro Medical) (2012-2017) 9.9 WideMed 9.9.1 Company Basic Information, Manufacturing Base and Competitors 9.9.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.9.2.1 Type one 9.9.2.2 Type two 9.9.3 WideMed Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 9.9.4 Main Business/Business Overview 9.10 CADWELL LABORATORIES 9.10.1 Company Basic Information, Manufacturing Base and Competitors 9.10.2 Sleep Apnea Diagnostic and Therapeutic Devices Product Types, Application and Specification 9.10.2.1 Type one 9.10.2.2 Type two 9.10.3 CADWELL LABORATORIES Sleep Apnea Diagnostic and Therapeutic Devices Sales, Revenue, Price and Gross Margin (2012-2017) 10.8.4 Main Business/Business Overview 9.11 SOMNOmedics GmbH 9.12 BMC Medical 9.13 Curative Medical 9.14 SnoreDoc 9.15 Contec Medical 9.16 Glidewell 9.17 Laboratories 9.18 SomnMed 9.19 Vital Sleep For more information, please visit https://www.wiseguyreports.com/sample-request/1004461-global-sleep-apnea-diagnostic-and-therapeutic-devices-sales-market-report-2017


Receive press releases from IQ4I Research & Consultancy Pvt. Ltd.: By Email IQ4I Research & Consultancy Published a New Report on "Brain Monitoring Devices Global Market – Forecast to 2023" Brain monitoring devices aid in understand the activity of brain and explore structure and functions. Increasing incidence and prevalence neurological diseases, rising awareness, technological advancements/innovations are driving the market growth. Boston, MA, April 25, 2017 --( Brain monitoring devices market is growing at a steady rate, as estimated by IQ4I Research the market is expected to reach $10.01billion by 2023. The major factors driving the brain monitoring device market includes growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, growing healthcare spending and technological advancements/innovations offering wider scope of applications for brain monitoring. However, some of the factors like shortage of trained professionals, high cost of complex devices, stringent regulations and unfavorable reimbursement policies may hinder the growth of global brain monitoring device market. The brain monitoring devices global market is segmented based on their products, applications, end users and geography. Among products, sleep monitoring devices holds the largest market share because of the advancements in portable sleep devices technologies and growing incidence of obstructive sleep apnea. Sleep monitoring devices is expected to grow at the single digit mid-CAGR. The global brain monitoring devices application segment is classified into neurodegenerative disorders, brain tumor, psychiatric disorders, sleep disorders and other applications. Neurodegenerative diseases are characterized by progressive loss of neurons in the central nervous system and Epilepsy, Parkinson's disease (PD), Huntington’s disease falls under this category. In 2016, the market was estimated to be dominated by neurodegenerative disorders. The large share of this segment can be attributed to the growing incidence of Traumatic Brain Injuries (TBIs) globally owing to various factors like, increasing occurrence of falls, blunt trauma and motor vehicle crashes among other causes of TBIs and along with the increasing aging population. Geographically, the bran monitoring devices market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America region held the largest market share within that United States accounted for the largest share this growth is driven due to its high acceptance of advanced technologies and sophisticated universal treatment facilities. Asia- Pacific region is the fastest growing region due to its increase in healthcare spending and advancements in healthcare facilities, the easy access to advanced healthcare technology. The global brain monitoring devices market is fragmented where key players like GE Healthcare (U.S.), Philips N.V. (Netherland), Siemens Healthineers (Germany), Medtronic (Ireland) and Natus Medical Inc. (U.S.) holding a major share in 2016. The protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage. According to IQ4I Analysis, Advanced Brain Monitoring filed the largest number of PCT applications followed by Siemens Healthineers and Philips N.V. at World Intellectual Property Organization (WIPO). Some of the prominent players in brain monitoring device market include Advanced Brain Monitoring (U.S.), Cadwell Laboratories (U.S.), CAS Medicals Inc. (U.S), Compumedics Limited (Australia), Electrical Geodesics Incorporated (U.S.), Elekta AB (Sweden), GE Healthcare (U.S.), Integra Lifesciences (U.S.), Koninklijke Philips N.V. (Netherland), Masimo corporation (U.S.), Medtronic (Ireland), Natus Medical Inc.(U.S.), Nihon Kohden Corporation (Japan) and Siemens Healthineers (Germany). Boston, MA, April 25, 2017 --( PR.com )-- Brain monitoring devices are used to monitor and diagnose the neurological conditions by exploring the structure and functions of the brain in patients. These devices provide the information of the brain and greater understanding of neurological problems, with possible new treatments. Among brain monitoring devices CT and MRI are the conventional devices which are being used for the structural diagnosis of the brain like tumour, head injury etc., whereas EEG, MEG, TCD, oximeters and ICP monitors are the recent techniques used for the functional imaging of the brain. EEG measures the electrical activity generated by the various cortical layers of the brain whereas, MEG capture the magnetic fields generated by neural activity within the brain. Similarly, TCD measures the velocity of the blood flow through the brain’s blood vessels, oximeters are used to measure the regional cerebral oxygen saturation with in the brain and ICP monitors monitor the intracranial pressure within the skull while treating severe traumatic brain injury in patients. In addition to all these devices, sleep monitoring devices which occupies major share in the brain monitoring devices global market, are being used to understand the person’s sleep physiology and track sleep with the aim of finding patterns and correlations with person’s behaviours.Brain monitoring devices market is growing at a steady rate, as estimated by IQ4I Research the market is expected to reach $10.01billion by 2023. The major factors driving the brain monitoring device market includes growing incidence and prevalence of neurological disorders, rising awareness about neurodegenerative disorders, growing healthcare spending and technological advancements/innovations offering wider scope of applications for brain monitoring. However, some of the factors like shortage of trained professionals, high cost of complex devices, stringent regulations and unfavorable reimbursement policies may hinder the growth of global brain monitoring device market.The brain monitoring devices global market is segmented based on their products, applications, end users and geography. Among products, sleep monitoring devices holds the largest market share because of the advancements in portable sleep devices technologies and growing incidence of obstructive sleep apnea. Sleep monitoring devices is expected to grow at the single digit mid-CAGR.The global brain monitoring devices application segment is classified into neurodegenerative disorders, brain tumor, psychiatric disorders, sleep disorders and other applications. Neurodegenerative diseases are characterized by progressive loss of neurons in the central nervous system and Epilepsy, Parkinson's disease (PD), Huntington’s disease falls under this category. In 2016, the market was estimated to be dominated by neurodegenerative disorders. The large share of this segment can be attributed to the growing incidence of Traumatic Brain Injuries (TBIs) globally owing to various factors like, increasing occurrence of falls, blunt trauma and motor vehicle crashes among other causes of TBIs and along with the increasing aging population.Geographically, the bran monitoring devices market is segmented into North America, Europe, Asia-Pacific and Rest of the World. North America region held the largest market share within that United States accounted for the largest share this growth is driven due to its high acceptance of advanced technologies and sophisticated universal treatment facilities. Asia- Pacific region is the fastest growing region due to its increase in healthcare spending and advancements in healthcare facilities, the easy access to advanced healthcare technology.The global brain monitoring devices market is fragmented where key players like GE Healthcare (U.S.), Philips N.V. (Netherland), Siemens Healthineers (Germany), Medtronic (Ireland) and Natus Medical Inc. (U.S.) holding a major share in 2016. The protection of intellectual property rights plays a very important role as a long term strategy for survival of the company and to maintain a competitive advantage. According to IQ4I Analysis, Advanced Brain Monitoring filed the largest number of PCT applications followed by Siemens Healthineers and Philips N.V. at World Intellectual Property Organization (WIPO).Some of the prominent players in brain monitoring device market include Advanced Brain Monitoring (U.S.), Cadwell Laboratories (U.S.), CAS Medicals Inc. (U.S), Compumedics Limited (Australia), Electrical Geodesics Incorporated (U.S.), Elekta AB (Sweden), GE Healthcare (U.S.), Integra Lifesciences (U.S.), Koninklijke Philips N.V. (Netherland), Masimo corporation (U.S.), Medtronic (Ireland), Natus Medical Inc.(U.S.), Nihon Kohden Corporation (Japan) and Siemens Healthineers (Germany). Click here to view the list of recent Press Releases from IQ4I Research & Consultancy Pvt. Ltd.


News Article | May 8, 2017
Site: www.prlog.org

-- Global brain monitoring market is expected to reach USD 2.0 billion by 2024 from USD 1.2 billion in 2016, at a CAGR of 7.1% in the forecast period 2017 to 2024.The global radiotherapy market is segmented based on therapy, product, application and geography.·         EEG·         TCD·         MEG·         MRI·         CT·         PET·         EMG·         Internal beam radiotherapy·         Systemic radiation therapy·         Traumatic Brain Injury (TBI)·         Headache, dementia·         Epilepsy·         ParkinsonBased on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world.·         Nihon Kohden Corporation·         Philips Healthcare, Metronic PLC·         GE Healthcare, Siemens Healthcare·         Natus Medical Incorporated, Compumedics Limited·         Electrical Geodesics, Inc. CAS Medical Systems Inc·         Advanced Brain Monitoring·         B. Braun Medical, Becton·         Dickinson & Company·         DePuySynthes Companies·         Cadwell Industries, Inc·         Masimo Corporation·         Elekta AB (pub)·         Integra LifeSciences Corporation·         Rimed Inc.·         Yokogawa Electric Corporation·         EMOTIV Inc.and Neural AnalyticsReport Access: http://databridgemarketresearch.com/ reports/global- radiot... Data Bridge Market Research4th Floor, Mega Center,Magarpatta City, Pune – 411028Tel: +1-888-387-2818Email: Sales@databridgemarketresearch.comVisit Data Bridge Blog@ http://databridgemarketresearch.com/blog/LinkedIn: https://www.linkedin.com/company/data-bridge-market-research


News Article | May 8, 2017
Site: www.prnewswire.com

·         Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. ·         Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. ·         The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023. ·         The global sleep aids market is segmented based on product, sleep disorder, and geography. ·         The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. Sleep Aids Market by Product (Mattress & Pillows, Sleep Laboratories, Medications, and Sleep Apnea Devices) and Sleep Disorder (Insomnia, Sleep Apnea, Restless Leg Syndrome, Narcolepsy, Sleep Walking, and Other Sleep Disorders) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Sleep aids are drugs and devices that are used to diagnose and treat sleep disorders, such as sleep apnea and insomnia. Sleep disorders are caused due to substance misuse, stressful work environment, and inconsistent sleep pattern. Sleep aids help to improve the quality of sleep by reducing the time required to fall asleep and increasing the duration of quality sleep. The global sleep aids market was valued at $49,543 million in 2016, and is estimated to reach $79,851 million by 2022, registering a CAGR of 7.0% from 2017 to 2023. The global sleep aids market is segmented based on product, sleep disorder, and geography. Based on product, it is categorized into mattress & pillows, sleep laboratories, medications, and sleep apnea devices. The medications segment is further divided into prescription-based drugs, over-the-counter (OTC) drugs, and herbal drugs. Based on sleep disorder, it is classified into insomnia, sleep apnea, restless leg syndrome, narcolepsy, sleep walking, and other sleep disorder. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. The market growth is attributed to the surge in prevalence of sleep disorders, rise in geriatric and obese population, and change in lifestyle. The surge in disposable income; increase in awareness about sleep disorders; stressful work issues; enhanced intake of caffeine, tobacco, and alcohol; and technological advancements are expected to boost the sleep aids market growth. However, adverse effects of sleep aids medication in patient with sleep disorders, such as dizziness, diarrhea, constipation, daytime drowsiness; and expiration on sleep drugs patents are expected to hamper the market growth. KEY MARKET BENEFITS This report offers a detailed quantitative analysis of the current market trends from 2016 to 2023 to identify the prevailing opportunities. Market estimations provided are based on comprehensive analysis of the key developments in the industry. The global market is comprehensively analyzed with respect to product, sleep disorder, and geography. In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning. The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market. KEY PLAYERS PROFILED Koninklijke Philips N.V. Merck & Co. Sanofi DeVilbiss Healthcare LLC. Pfizer Inc. SleepMed Inc. Cadwell Laboratories Inc. Compumedics Limited Natus Medical Incorporated GlaxoSmithKline plc. Sleep Aids Market Key Segments BY PRODUCT Mattresses & Pillows Sleep Laboratories Medications Prescription-based drugs OTC drugs Herbal drugs Sleep Apnea Devices BY SLEEP DISORDER Insomnia Sleep Apnea Restless Legs Syndrome Narcolepsy Sleep Walking Other Sleep Disorders BY GEOGRAPHY North America U.S. Canada Mexico Europe Germany UK France Spain Rest of Europe Asia-Pacific Japan China Australia India Rest of Asia-Pacific LAMEA Brazil Turkey Republic of South Africa Saudi Arabia Read the full report: http://www.reportlinker.com/p04883729/Sleep-Aids-Market-Global-Opportunity-Analysis-and-Industry-Forecast.html About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. http://www.reportlinker.com __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/sleep-aids-market-is-estimated-to-reach-79851-million-by-2022-300453104.html


Pritchett S.,Monash University | Pritchett S.,Compumedics Pty Ltd. | Zilberg E.,Compumedics Pty Ltd. | Xu Z.M.,Compumedics Pty Ltd. | And 4 more authors.
BioMedical Engineering Online | Year: 2010

Background: Changes in nonlinear neuronal mechanisms of EEG generation in the course of general anaesthesia have been extensively investigated in research literature. A number of EEG signal properties capable of tracking these changes have been reported and employed in anaesthetic depth monitors. The degree of phase coupling between different spectral components is a marker of nonlinear EEG generators and is claimed to be an important aspect of BIS. While bicoherence is the most direct measure of phase coupling, according to published research it is not directly used in the calculation of BIS, and only limited studies of its association with anaesthetic depth and level of consciousness have been published. This paper investigates bicoherence parameters across equal band and unequal band bifrequency regions, during different states of anaesthetic depth relating to routine clinical anaesthesia, as determined by visual inspection of EEG.Methods: 41 subjects scheduled for day surgery under general anaesthesia were recruited into this study. EEG bicoherence was analysed using average and smoothed-peak estimates calculated over different regions on the bifrequency plane. Statistical analysis of associations between anaesthetic depth/state of consciousness and bicoherence estimates included linear regression using generalised linear mixed effects models (GLMs), ROC curves and prediction probability (Pk).Results: Bicoherence estimates for the δ_θ region on the bifrequency plane were more sensitive to anaesthetic depth changes compared to other bifrequency regions. Smoothed-peak bicoherence displayed stronger associations than average bicoherence. Excluding burst suppression and large transients, the δ_θ peak bicoherence was significantly associated with level of anaesthetic depth (z = 25.74, p < 0.001 and R2= 0.191). Estimates of Pkfor this parameter were 0.889(0.867-0.911) and 0.709(0.689-0.729) respectively for conscious states and anaesthetic depth levels (comparable BIS estimates were 0.928(0.905-0.950) and 0.801(0.786-0.816)). Estimates of linear regression and areas under ROC curves supported Pkfindings. Bicoherence for eye movement artifacts were the most distinctive with respect to other EEG patterns (average |z| value 13.233).Conclusions: This study quantified associations between deepening anaesthesia and increase in bicoherence for different frequency components and bicoherence estimates. Increase in bicoherence was also established for eye movement artifacts. While identified associations extend earlier findings of bicoherence changes with increases in anaesthetic drug concentration, results indicate that the unequal band bifrequency region, δ_θ, provides better predictive capabilities than equal band bifrequency regions. © 2010 Pritchett et al; licensee BioMed Central Ltd.


Zion Research has published a new report titled “Blood Flow Measurement Devices Market (Laser Doppler Blood Flowmeters, Electromagnetic Blood Flowmeters and Ultrasonic Doppler Blood Flowmeters) for Diabetes, Peripheral Vascular Diseases, Dermatology, Gastroenterology, Tumor Monitoring and Other Applications: Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021”. According to the report, global demand for the blood flow measurement devices market was valued at around USD 354.2million in 2015 and is expected to generate revenue of around USD 554.3 million by end of 2021, growing at a CAGR of around 7.8% between 2016 and 2021. Blood flow measurement devices are typically used for measurement of blood flow. This rate is calculated based on the amount of blood passing through a cross section of a blood vessel per unit time. It is used to obtainvascular assessment data by the blood flow measurement devices which help physicians to maintain the equilibrium between demand and supply of tissue oxygen of patients.Blood flow measurement devices play a very vital role in detection of number of clinical vascular conditions such as peripheral vascular diseases such as diabetic macroandmicro vascular complications and arterial occlusion.Some of the different types of blood flow measurement devices include laser doppler blood flowmeters, electromagnetic blood flowmeters and ultrasonic doppler blood flowmeters. Global blood flow measurement devices market is primarily driven by rising number of target disease such as peripheral artery diseases, diabetes, etc. across the globe. Other major driving factors aregrowing geriatric population coupled along with increasing demand for non-invasive surgeries and technologically advanced devices. However, high price of these devices and stringent regulatory policies are the major restraints that may limit the growth of the market. Nonethelessincreasing clinical applications coupled along with emerging markets across the globearelikely to disclose the new avenues for blood flow measurement devices market in the near future. The blood flow measurement devices market is segmented on the basis of different products including laser doppler blood flowmeters, electromagnetic blood flowmeters, and ultrasonic doppler blood flowmeters. In 2015, ultrasonic doppler blood flow meters was the largest segment in blood flow measurement devices market and accounted for largest share of the total market. Additionally, it is expected to continue its dominance in global market over the forecast period. Diabetes, peripheral vascular diseases, dermatology, gastroenterology, tumor monitoring and others are the key application of the global blood flow measurement devices market. The peripheral vascular diseasesegment dominated the market in terms of revenue and is expected to show moderategrowth within the forecast period. Know more before buying this report @  https://www.zionmarketresearch.com/inquiry/blood-flow-measurement-devices-market North America, Europe, Asia-Pacific, Latin America and Middle East & Africa are key regional segments of global blood flow measurement devices market. North America is anticipated to remain the leading region over the forecast period in 2015. Demand for blood flow measurement devices was highest in Asia-Pacific. Hence, Asia Pacific is expected to be the fastest growing region in blood flow measurement devices market during the forecast period. Moreover, Middle East and Africa and Latin America are also expected to show moderate growth for this market in the years to come. Some of the key players in the blood flow measurement devices market include Cook Medical Inc., Atys Medical, Deltex Medical, ArjoHuntleigh Inc.,Elcat GmBH, Compumedics Ltd.,Moor Instruments Ltd., GF Health Products, Inc., and Transonic Systems Inc.,.Medistim ASA, and Perimed AB among others. This report segments the global blood flow measurement devices market as follows:

Loading Compumedics Pty Ltd. collaborators
Loading Compumedics Pty Ltd. collaborators